These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14617616)

  • 1. Heparin and angiogenesis: size matters!
    Rak J; Weitz JI
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):1954-5. PubMed ID: 14617616
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin, low molecular weight heparin, and derivatives in thrombosis, angiogenesis, and inflammation: emerging links.
    Mousa SA
    Semin Thromb Hemost; 2007 Jul; 33(5):524-33. PubMed ID: 17629850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-anticoagulant effects of unfractionated and low-molecular weight heparins.
    Walenga JM
    Clin Adv Hematol Oncol; 2007 Oct; 5(10):759-60. PubMed ID: 17998892
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparins and angiogenesis.
    Norrby K
    APMIS; 2006 Feb; 114(2):79-102. PubMed ID: 16519745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparin in thrombosis and cancer.
    Mousa SA
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():25-30. PubMed ID: 15085463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of angiogenesis: thalidomide or low-molecular-weight heparin?
    Ozkan M; Eser B; Er O; Dogu GG; Altinbas M
    J Clin Oncol; 2005 Mar; 23(9):2113; author reply 2113-4. PubMed ID: 15774812
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiovascular system drugs. 10/12. The heparins].
    Nerich V; Limat S; Woronoff-Lemsi MC
    Soins; 2005 Mar; (693):51-3. PubMed ID: 15796485
    [No Abstract]   [Full Text] [Related]  

  • 9. Comment: venous thromboembolism prophylaxis conversion in nonsurgical inpatients.
    Groce JB
    Ann Pharmacother; 2003 Dec; 37(12):1915-6; reply 1916-7. PubMed ID: 14632546
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment: venous thromboembolism prophylaxis conversion in nonsurgical inpatients.
    Fanikos J; Tsilimingras K
    Ann Pharmacother; 2003 Dec; 37(12):1914-5; reply 1916-7. PubMed ID: 14632547
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparins, low-molecular-weight heparins, and pentasaccharides.
    Dinwoodey DL; Ansell JE
    Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin in hypertriglyceridemia: friend or foe?
    Ng D
    J Lab Clin Med; 2001 Dec; 138(6):356-8. PubMed ID: 11753281
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of angiogenesis and tumor growth by orally active deoxycholic acid-heparin conjugate.
    Lee DY; Kim SK; Kim YS; Son DH; Nam JH; Kim IS; Park RW; Kim SY; Byun Y
    J Control Release; 2007 Apr; 118(3):310-7. PubMed ID: 17291620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low-molecular-weight heparins versus unfractionated heparin for treatment of hemodialysed patients].
    Kes P; Basić-Jukić N; Jurić I
    Lijec Vjesn; 2007; 129(8-9):305-8. PubMed ID: 18198633
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of thromboembolism in pregnancy.
    Marks PW
    Semin Perinatol; 2007 Aug; 31(4):227-31. PubMed ID: 17825678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?
    Hull RD; Pineo GF
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():11-23. PubMed ID: 15085462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin as bridging anticoagulation.
    van Dongen CJ; Vink R; Levi M
    Arch Intern Med; 2004 Dec 13-27; 164(22):2500. PubMed ID: 15596646
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical studies with anticoagulants to improve survival in cancer patients.
    Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
    Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heparin and cancer].
    Lykke J
    Ugeskr Laeger; 2006 Dec; 168(50):4397-401. PubMed ID: 17217864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low- and ultra-low-molecular-weight heparins.
    Kakkar AK
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):77-87. PubMed ID: 15171959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.